181 related articles for article (PubMed ID: 27759908)
21. HOX11L2 expression defines a clinical subtype of pediatric T-ALL associated with poor prognosis.
Ballerini P; Blaise A; Busson-Le Coniat M; Su XY; Zucman-Rossi J; Adam M; van den Akker J; Perot C; Pellegrino B; Landman-Parker J; Douay L; Berger R; Bernard OA
Blood; 2002 Aug; 100(3):991-7. PubMed ID: 12130513
[TBL] [Abstract][Full Text] [Related]
22. Characterization of a pediatric T-cell acute lymphoblastic leukemia patient with simultaneous LYL1 and LMO2 rearrangements.
Homminga I; Vuerhard MJ; Langerak AW; Buijs-Gladdines J; Pieters R; Meijerink JP
Haematologica; 2012 Feb; 97(2):258-61. PubMed ID: 22058201
[TBL] [Abstract][Full Text] [Related]
23. The role of CDKN2A/B deletions in pediatric acute lymphoblastic leukemia.
Carrasco Salas P; Fernández L; Vela M; Bueno D; González B; Valentín J; Lapunzina P; Pérez-Martínez A
Pediatr Hematol Oncol; 2016; 33(7-8):415-422. PubMed ID: 27960642
[TBL] [Abstract][Full Text] [Related]
24. NOTCH1 activation clinically antagonizes the unfavorable effect of PTEN inactivation in BFM-treated children with precursor T-cell acute lymphoblastic leukemia.
Bandapalli OR; Zimmermann M; Kox C; Stanulla M; Schrappe M; Ludwig WD; Koehler R; Muckenthaler MU; Kulozik AE
Haematologica; 2013 Jun; 98(6):928-36. PubMed ID: 23349303
[TBL] [Abstract][Full Text] [Related]
25. Deletion of CDKN2A/B is associated with inferior relapse free survival in pediatric B cell acute lymphoblastic leukemia.
Kathiravan M; Singh M; Bhatia P; Trehan A; Varma N; Sachdeva MS; Bansal D; Jain R; Naseem S
Leuk Lymphoma; 2019 Feb; 60(2):433-441. PubMed ID: 29966470
[TBL] [Abstract][Full Text] [Related]
26. [A tal-1 deletion as real-time quantitative polymerase chain reaction target for detection of minimal residual disease in T-lineage acute lymphoblastic leukemia].
Wang L; Zhang LP; Li ZG; Cheng YF; Tian KG; Lu AD
Zhonghua Er Ke Za Zhi; 2005 Mar; 43(3):170-3. PubMed ID: 15833185
[TBL] [Abstract][Full Text] [Related]
27. Negative prognostic impact of PTEN mutation in pediatric T-cell acute lymphoblastic leukemia.
Jotta PY; Ganazza MA; Silva A; Viana MB; da Silva MJ; Zambaldi LJ; Barata JT; Brandalise SR; Yunes JA
Leukemia; 2010 Jan; 24(1):239-42. PubMed ID: 19829307
[No Abstract] [Full Text] [Related]
28. Clinical and biological relevance of genetic alterations in pediatric T-cell acute lymphoblastic leukemia in Taiwan.
Yeh TC; Liang DC; Liu HC; Jaing TH; Chen SH; Hou JY; Yang CP; Huang YJ; Yao HW; Huang TY; Lin TH; Shih LY
Pediatr Blood Cancer; 2019 Jan; 66(1):e27496. PubMed ID: 30280491
[TBL] [Abstract][Full Text] [Related]
29. Occurrence of t(8;22)(q24.1;q11.2) involving the MYC locus in a case of pediatric acute lymphoblastic leukemia with a precursor B cell immunophenotype.
Gupta AA; Grant R; Shago M; Abdelhaleem M
J Pediatr Hematol Oncol; 2004 Aug; 26(8):532-4. PubMed ID: 15284595
[TBL] [Abstract][Full Text] [Related]
30. Acute lymphoblastic leukemia (ALL) with t(8;14)(q11.2;q32) in an elderly patient.
Kubo Y; Kakazu N; Tasaka T; Oka D; Hirose T; Matsuhashi Y; Wada H; Tohyama K; Sugihara T
Leuk Res; 2010 Mar; 34(3):e82-4. PubMed ID: 19573915
[TBL] [Abstract][Full Text] [Related]
31. The presence of mutated and deleted PTEN is associated with an increased risk of relapse in childhood T cell acute lymphoblastic leukaemia treated with AIEOP-BFM ALL protocols.
Paganin M; Grillo MF; Silvestri D; Scapinello G; Buldini B; Cazzaniga G; Biondi A; Valsecchi MG; Conter V; Te Kronnie G; Basso G
Br J Haematol; 2018 Sep; 182(5):705-711. PubMed ID: 29938780
[TBL] [Abstract][Full Text] [Related]
32. The significance of PTEN and AKT aberrations in pediatric T-cell acute lymphoblastic leukemia.
Zuurbier L; Petricoin EF; Vuerhard MJ; Calvert V; Kooi C; Buijs-Gladdines JG; Smits WK; Sonneveld E; Veerman AJ; Kamps WA; Horstmann M; Pieters R; Meijerink JP
Haematologica; 2012 Sep; 97(9):1405-13. PubMed ID: 22491738
[TBL] [Abstract][Full Text] [Related]
33. Characteristics and therapeutic approaches for patients diagnosed with T-ALL/LBL exhibiting t(8;14)(q24;q11)/TCRA/D:MYC translocation.
Zhang X; Wang T; Zhang Y; Wang F; Chen J; Ni J; Sun R; Wei Z; Zhang G; Li W; Li J; Lu P
Leuk Lymphoma; 2023 Dec; 64(13):2133-2139. PubMed ID: 37674391
[TBL] [Abstract][Full Text] [Related]
34. Age-related clinical and biological features of PTEN abnormalities in T-cell acute lymphoblastic leukaemia.
Tesio M; Trinquand A; Ballerini P; Hypolite G; Lhermitte L; Petit A; Ifrah N; Baruchel A; Dombret H; Macintyre E; Asnafi V
Leukemia; 2017 Dec; 31(12):2594-2600. PubMed ID: 28539671
[TBL] [Abstract][Full Text] [Related]
35. Gene fusions AHRR-NCOA2, NCOA2-ETV4, ETV4-AHRR, P4HA2-TBCK, and TBCK-P4HA2 resulting from the translocations t(5;8;17)(p15;q13;q21) and t(4;5)(q24;q31) in a soft tissue angiofibroma.
Panagopoulos I; Gorunova L; Viset T; Heim S
Oncol Rep; 2016 Nov; 36(5):2455-2462. PubMed ID: 27633981
[TBL] [Abstract][Full Text] [Related]
36. [Genetic basis of pediatric T-cell acute lymphoblastic leukemia and its clinical impact].
Takita J
Rinsho Ketsueki; 2018; 59(7):953-959. PubMed ID: 30078808
[TBL] [Abstract][Full Text] [Related]
37. [Tal1 promotes proliferation of acute lymphoblastic leukemia Jurkat cells in vitro].
Wang Y; Shu Y; Yuan J; Chen H; Zou L
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Jan; 36(1):78-82. PubMed ID: 26806743
[TBL] [Abstract][Full Text] [Related]
38. Core transcriptional regulatory circuit controlled by the TAL1 complex in human T cell acute lymphoblastic leukemia.
Sanda T; Lawton LN; Barrasa MI; Fan ZP; Kohlhammer H; Gutierrez A; Ma W; Tatarek J; Ahn Y; Kelliher MA; Jamieson CH; Staudt LM; Young RA; Look AT
Cancer Cell; 2012 Aug; 22(2):209-21. PubMed ID: 22897851
[TBL] [Abstract][Full Text] [Related]
39. Constitutional t(8;22)(q24;q11.2) that mimics the variant Burkitt-type translocation in Philadelphia chromosome-positive chronic myeloid leukemia.
Kawamoto S; Yamamoto K; Toyoda M; Yakushijin K; Matsuoka H; Minami H
Int J Hematol; 2017 Feb; 105(2):226-229. PubMed ID: 27686674
[TBL] [Abstract][Full Text] [Related]
40. Deregulated expression of the TAL1 gene by t(1;5)(p32;31) in patient with T-cell acute lymphoblastic leukemia.
François S; Delabesse E; Baranger L; Dautel M; Foussard C; Boasson M; Blanchet O; Bernard O; Macintyre EA; Ifrah N
Genes Chromosomes Cancer; 1998 Sep; 23(1):36-43. PubMed ID: 9713995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]